Aging Male is an esteemed peer-reviewed journal published by Taylor & Francis Ltd, dedicated to the multidisciplinary field of geriatrics and gerontology. With an impressive impact factor, this journal ranks in the top quartile (Q2) of its categories, solidifying its reputation as a leading source of research and insights for professionals and academics in the field. Since transitioning to Open Access in 2021, Aging Male has broadened its reach, facilitating the dissemination of relevant research findings that address the complexities of aging in male populations globally. The journal accepts a wide range of contributions, including original research, reviews, and clinical studies, with particular emphasis on the biological, psychological, and social aspects of male aging. Researchers, clinicians, and students alike will find this journal an invaluable resource for advancing knowledge and practice in the dynamic landscape of geriatric medicine.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, published by SpringerNature, stands as a revered platform in the field of urology, particularly focusing on issues related to male sexual health and dysfunction. Since its inception in 1993, this journal has consistently provided cutting-edge research, reviews, and clinical studies, all directed towards advancing our understanding of impotence and related conditions. With an impressive ranking of 26th out of 120 journals in the Scopus category of Medicine_Urology (percentile 78th), it holds a crucial place as a Q2 journal, reflecting its substantial impact and influence in the field. Researchers, professionals, and students alike can benefit from the wealth of knowledge presented in its pages, contributing to their studies and clinical applications. While the journal is not open access, it ensures high-quality content curated by leading experts, fostering essential discourse in an often stigmatized yet significant area of health.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.

Nature Reviews Urology, published by NATURE PORTFOLIO, stands as a leading journal in the field of urology, showcasing cutting-edge research and reviews that address the complexities and advancements within this dynamic medical specialty. With a 2023 impact factor that places it firmly in the Q1 quartile of urology journals, it ranks impressively within the top 3 out of 120 in Scopus, highlighting its critical role in disseminating significant academic findings. As a premier source of scholarly information, this journal aims to provide urology professionals, researchers, and students with comprehensive insights into the latest clinical practices, therapeutic developments, and technological innovations, promoting a deeper understanding of urological conditions. The journal also ensures accessibility to its articles, demonstrating a commitment to the open dissemination of knowledge essential for advancing urology research and practice.

Journal of Men's Health, published by MRE PRESS, is a leading open-access journal dedicated to advancing research in the field of men's health and urology. Since its inception in 2008, this journal has provided a vital platform for interdisciplinary research, emphasizing the unique health issues affecting men. With an E-ISSN of 1875-6859, the journal has established a strong presence in the academic community, proudly achieving an open access model since 2015, which enhances accessibility for researchers and practitioners worldwide. As of 2023, it holds a Q4 ranking in Medicine (miscellaneous) and a Q3 ranking in Urology, underscoring its commitment to disseminating high-quality research amidst an evolving medical landscape. Positioned in Singapore, the Journal of Men's Health not only aims to foster knowledge exchange among professionals and scholars but also seeks to promote innovative solutions that address men's health challenges, making it a crucial resource for both existing and emerging health practitioners and researchers.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Sexual Medicine, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of sexual health and medicine since its inception in 2013. With an E-ISSN of 2050-1161, this journal provides a platform for high-quality research that spans multiple disciplines including Behavioral Neuroscience, Dermatology, Endocrinology, Psychiatry and Mental Health, and Reproductive Medicine. Notably, the journal has maintained a solid standing in its category quartiles, with rankings reflecting its significant impact in the fields of Urology (Rank #18/120, 85th Percentile) and Reproductive Medicine (Rank #25/90, 72nd Percentile), among others. The open-access model enhances accessibility to groundbreaking research, ensuring that knowledge is disseminated widely to researchers, healthcare professionals, and students alike. With a commitment to fostering a deeper understanding of the complexities surrounding sexual health, Sexual Medicine endeavors to provide critical insights and foster discussions that drive innovation and improvement in clinical practices. Discover more and stay updated on the latest findings in sexual health by engaging with this invaluable resource on a global scale.